ISUPREL Drug Patent Profile
✉ Email this page to a colleague
When do Isuprel patents expire, and what generic alternatives are available?
Isuprel is a drug marketed by Sanofi Aventis Us and Bausch and is included in four NDAs.
The generic ingredient in ISUPREL is isoproterenol hydrochloride. There are seventeen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the isoproterenol hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Isuprel
A generic version of ISUPREL was approved as isoproterenol hydrochloride by NEXUS on August 2nd, 2017.
Summary for ISUPREL
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 118 |
Clinical Trials: | 5 |
Patent Applications: | 963 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for ISUPREL |
What excipients (inactive ingredients) are in ISUPREL? | ISUPREL excipients list |
DailyMed Link: | ISUPREL at DailyMed |
Recent Clinical Trials for ISUPREL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Brain & Behavior Research Foundation | N/A |
Vanderbilt University Medical Center | N/A |
Vanderbilt University | N/A |
US Patents and Regulatory Information for ISUPREL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sanofi Aventis Us | ISUPREL | isoproterenol hydrochloride | AEROSOL, METERED;INHALATION | 011178-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sanofi Aventis Us | ISUPREL | isoproterenol hydrochloride | SOLUTION;INHALATION | 006327-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bausch | ISUPREL | isoproterenol hydrochloride | INJECTABLE;INJECTION | 010515-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sanofi Aventis Us | ISUPREL | isoproterenol hydrochloride | SOLUTION;INHALATION | 006327-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sanofi Aventis Us | ISUPREL | isoproterenol hydrochloride | TABLET;RECTAL, SUBLINGUAL | 006328-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |